Transcatheter heart valves technologies

Mean compression ratio of a self-expandable valve is associated with the need for pacemaker implantation after transcatheter aortic valve replacement

Published on 01/02/2024 | Qi Yiming 1 et al. | European journal of medical research 2023; 29(1): 85 | 16 minute read

Abstract Background The risk and timing of permanent pacemaker implantation (PPMI) after transcatheter aortic valve replacement (TAVR) is still hard

Transcatheter heart valves technologies

Iatrogenic bioprosthetic, self-expandable, transcatheter aortic valve replacement (TAVR) dysfunction after cardiac catheterization

Published on 01/02/2024 | Aslan Amirian et al. | European journal of cardio-thoracic surgery 2024; aop: 10.1093/ejcts/ezae021 | 0 minute read

Transcatheter heart valves technologies

Transcatheter pulmonary valve replacement in surgically‐created double‐barrel right ventricular outflow tracts: A single center case‐series

Published on 18/01/2024 | Nicholas Seizo BoscampMD et al. | Catheterization and Cardiovascular Interventions 2024; AOP: 10.1002/ccd.30954 | 16 minute read

Abstract This manuscript describes the feasibility and approach to the assessment and performance of transcatheter pulmonary valve replacement (tPVR) in

Transcatheter heart valves technologies

Transcatheter aortic valve replacement in patients with a pre-existing prosthetic mitral valve: a single center experience with two cases

Published on 18/01/2024 | Kushimo Oyewole A. 1 et al. | The Egyptian Heart Journal 2024; 76(1): 3 | 10 minute read

Abstract Background The performance of transcatheter aortic valve replacement (TAVR) in patients with pre-existing prosthetic mitral valves is technically challenging

Transcatheter heart valves technologies

Secondary retensioning of a tether-based device for transapical transcatheter mitral valve implantation

Published on 04/01/2024 | Martin Beyer et al. | European journal of cardio-thoracic surgery 2023; aop: 10.1093/ejcts/ezad430 | 0 minute read

Transcatheter heart valves technologies

Percutaneous coronary intervention: Before, after, or during TAVR?

Published on 04/01/2024 | Ivan HansonMD et al. | Catheterization and Cardiovascular Interventions 2023; AOP: 10.1002/ccd.30941 | 5 minute read

Abstract Key points Decisions surrounding if, and when, to perform coronary revascularization in patients undergoing trans‐catheter aortic valve replacement (TAVR)

Transcatheter heart valves technologies

Evaluation of cerebrovascular events via retinal angiography during transcatheter aortic valve implantation

Published on 21/12/2023 | Qian Henna a Piuhola Jarkko a Kiviniemi Heidi a b Niemelä Matti a Hautala Nina c Junttila Juhani a a Research Unit of Internal Medicine et al. | Scandinavian Cardiovascular Journal 2023; 57(1): | 0 minute read

Transcatheter heart valves technologies

Transcatheter mitral valve replacement with Mi‐thos system: First‐in‐human experience

Published on 21/12/2023 | Ye YangMD 1 et al. | Catheterization and Cardiovascular Interventions 2023; AOP: 10.1002/ccd.30926 | 13 minute read

Abstract Background Transcatheter mitral valve replacement (TMVR) has become an alternative for high‐risk patients with severe mitral regurgitation (MR). The

Transcatheter heart valves technologies

Coronary microvascular dysfunction in patients undergoing transcatheter aortic valve implantation

Published on 07/12/2023 | Roberto Scarsini 1 et al. | Heart 2023; aop:10.1136/heartjnl-2023-323461 | 21 minute read

Abstract Objectives This study aimed to evaluate the prognostic value of coronary microvascular dysfunction (CMD) at long term after transcatheter

Transcatheter heart valves technologies

Unusual cause of myocardial infarction following transcatheter aortic valve replacement

Published on 07/12/2023 | NeerajShah 1 et al. | Clinical case reports 2023; 11(11): 8091 | 9 minute read

Key Clinical Message Left coronary artery embolism from aortic valve leaflet tissue mass is a rare but potentially life‐threatening complication

This bibliographical database is provided by GNM Healthcare Group Companies USA, Inc. in full editorial independence.

The information published within the framework of this service may discuss or suggest certain therapies that have not been validated by the competent national authorities.
Service exclusively reserved for healthcare professionals.